X-37

is an artificial intelligence-enabled drug discovery company that develops molecules for the treatment of cancer and tumor...
Read more
X-37 Co-Founder & CEO: David J. Collier

Co-Founder & CEO

David J. Collier

CEO Approval Rating

90/100

2018

PrivateIndependent Company

2836 NAICS listing
Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$14.5M

X-37 Competitors

1Recursion
2Genesis Therapeutics
3twoXAR
4BERG
5BPS Bioscience
6Cyclica
7Owkin
8Verge Genomics
9Exscientia
10Atomwise
See 18+ competitors

Trending Companies